What is the Foresight Accelerated Inheritance Tax Solution?
Real Assets
We build future energy systems and resilient infrastructure, backing emerging opportunities in technology, land and water.
Real Assets
Private Equity & Ventures
Real Assets
Private Equity & Ventures
This page is designed for use by St. James's Place partners. Here you will find the latest Foresight Accelerated Inheritance Tax Solution (AITS) information, fund manager views and important literature available to download.
Don't invest unless you're prepared to lose all the money you invest. This is a high-risk investment. Take 2 mins to learn more.
What is the Foresight Accelerated Inheritance Tax Solution?
The Foresight Accelerated Inheritance Tax Solution (Foresight Accelerated ITS) uniquely blends Business Relief (BR) and life insurance, giving investors immediate IHT mitigation. Since the Foresight Accelerated ITS was launched in 2016, over £300 million has been invested, with 99% of claims* having been successful
How does it work?
The innovative solution works by investing in shares that should qualify for BR, which renders shares exempt from IHT after being held for two years. The integrated insurance cover is designed to give additional peace of mind during this initial two-year period.
*The remaining 1% consists of unsuccessful and/or pending claims.
For more information on the basics of BR, the benefits, the rules and more, take a look at our BR guide.
Download our guide to find out more about how to calculate whether an individual’s estate will be liable for IHT, the main exemptions and the four pillars of IHT planning.
When you subscribe to the Foresight Accelerated ITS, your subscription amount, minus the agreed charges, will be used to acquire shares in one or more trading companies on your behalf. We invest across a range of underlying trades, including infrastructure and energy, to ensure you have a diversified portfolio of underlying investments.
The Foresight Accelerated ITS benefits from Insurance Cover for the first two years of your investment. The Insurance Cover available to you depends on if you are an individual investor (Single Life Cover) or joint investors (Joint Life Second Death Cover).
Once you have held your shares for two years, they should be exempt from IHT. If you die within the initial two-year period, and you are protected by your Insurance Cover, the insurance proceeds will mitigate the IHT liability on your investment. As with any shareholding, should you wish to access your investment, you can request that some or all of your shares are sold, subject to liquidity. Any withdrawal reduces the value of your investment.
Partial withdrawals are not permitted during the Initial Period other than to meet ongoing adviser fees. During the Initial Period, only a full withdrawal will be possible, however, please note that this will terminate your cover under the Insurance Policy and you will lose your IHT shelter. We will assist you in joining the Foresight ITS should you wish for any part of your investment to continue in a Foresight BR solution.
Single Life Cover: For individual investors only and pays out on an eligible death within the initial period
Maximum net investment: £1 million
Joint Life Second Death Cover: For joint investors only and pays out on the second death only (both deaths must be within the initial period and must be eligible deaths)
Maximum net investment: £2 million
Initial Charge: 2.50%
Initial Period Annual Management Charges:
Single Life Cover (Annual Management Charge (% of Net Investment Amount)):
Joint Life Second Death Cover (Annual Management Charge (% of Net Investment Amount)):
Annual Administration Charge: 2.00% plus VAT*
*Charge subject to VAT but reclaimed in whole or part where possible.
Investors must be aged between 62 – 89 years old (inclusive).
Cover provided without medical examination or questionnaire (simply requires your client to sign a declaration that to the best of their knowledge they are not suffering from a Terminal Illness).
You have viewed 0 of 0
Capital is at risk. The value of an investment, and any income from it can fall as well as rise and investors may not get back the full amount they invest. Foresight Inheritance Tax Solution (“ITS”), Accelerated Inheritance Tax Solution (“AITS”) and Enhanced Inheritance Tax Fund (“EITS”) should be considered longer-term investments and may be higher risk and more difficult to realise than an investment in listed securities. Investments will be made in small unquoted companies, which carry a higher risk than many other forms of investment. These investments will be illiquid and may expose you to a significant risk of losing all of the money you invest. Tax reliefs are dependent on investee companies continuing to qualify for Business Property Relief and investors’ individual circumstances. Current tax rules are subject to change. A failure to meet the BPR qualifying requirements could result in the investments losing their inheritance tax exempt status, resulting in adverse tax consequences for investors.
AITS is a part of the ITS Fund and is an integrated Business Relief and insurance solution that gives investors immediate inheritance tax mitigation. For investment in the AITS Fund, insurance cover is only available to investors who meet the eligibility criteria for the relevant Insurance Category. Failure to meet such criteria or a misrepresentation in the eligibility declaration could result in the Insurer refusing to settle an investor’s claim under the Insurance Policy.
Investors should only invest in ITS, AITS and EITS on the basis of information contained in the applicable Documentation (including any Brochure, Fund Prospectus, Offer Documents, Key Information Documents and Disclosure Documentation) or Terms and Conditions of Investment as appropriate.
Please refer to our Risk Warnings page for full general and specific risk information.
MICAP is part of Defaqto, an independent researcher of financial products and is not authorised to provide financial advice. Foresight does not have any influence or control over the Defaqto ratings or MICAP reviews including the methodology used. Foresight cannot accept responsibility for their accuracy and should not be relied upon for investment decisions. Ratings and reviews, including their use by Foresight, might be subject to change and are not indicative of any future performance. For further information on Defaqto and MICAP, please refer to the following resources: https://www.defaqto.com, www.micap.com/review/69 and www.micap.com/review/565.